Everolimus Rescue Treatment for Chronic Rejection After Pediatric Living Donor Liver Transplantation: 2 Case Reports

2018 ◽  
Vol 50 (9) ◽  
pp. 2872-2876 ◽  
Author(s):  
T. Ueno ◽  
S. Hiwatashi ◽  
R. Saka ◽  
H. Yamanaka ◽  
Y. Takama ◽  
...  
2017 ◽  
Vol 45 (6) ◽  
pp. 2146-2152 ◽  
Author(s):  
Guoyong Chen ◽  
Janjun Sun ◽  
Sidong Wei ◽  
Yongfeng Chen ◽  
Gaofeng Tang ◽  
...  

ABO-incompatible (ABO-i) living-donor liver transplantation (LDLT) is performed if an ABO-compatible graft cannot be obtained. However, a perfect desensitization protocol has not been established worldwide, especially for simultaneous ABO-i LDLT and splenectomy. We herein report two cases of ABO-i LDLT. To the best of our knowledge, this is the first case report of ABO-i LDLT in an adult patient in China. Splenectomy and T-cell-targeted immunosuppression (basiliximab) was used to overcome the blood group barrier in these recipients. The patients had good graft function without signs of antibody-mediated rejection throughout the 12-month follow-up. Thus, ABO-i LDLT with splenectomy is undoubtedly life-saving when an ABO-compatible graft cannot be obtained for patients in critical condition.


2018 ◽  
Vol 32 (2) ◽  
pp. e13161 ◽  
Author(s):  
Narendra Singh Choudhary ◽  
Neeraj Saraf ◽  
Sanjiv Saigal ◽  
Dheeraj Gautam ◽  
Amit Rastogi ◽  
...  

2020 ◽  
Vol 52 (6) ◽  
pp. 1829-1832 ◽  
Author(s):  
Takehisa Ueno ◽  
Tasuku Kodama ◽  
Yuki Noguchi ◽  
Koichi Deguchi ◽  
Motonari Nomura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document